Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 605
Recruiting: 316
Ph III recruiting: 30
Growth YoY: +37.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (571)

clinicaltrialsPublishedShowing 101–141 of 141 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01882946	Safety and Efficacy Study of DCVax-Direct in Solid Tumors	unknown	Phase 1 / Phase 2	60	Northwest BiotherapeuticsINDUSTRY	1	Oct 7, 2015	clinicaltrials
NCT01729663	Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients	unknown	Phase 2 / Phase 3	108	Laboratorio Pablo Cassara S.R.L.INDUSTRY	1	Sep 2, 2015	clinicaltrials